Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Oryza Pharmaceuticals Inc. with status Current. The shortage was first posted on 10/12/2022. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Oryza Pharmaceuticals Inc.
- Package NDC
- 72516-011-01
- Dosage Form
- Tablet
- Presentation
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)
- Initial Posting
- 10/12/2022
- Revised Date
Reason
Shortage of an active ingredient